EUCTR2012-004053-88-GBActive, not recruitingPhase 1
Second International Inter-Group Study for Classical Hodgkin's Lymphoma in Children and Adolescents - EuroNet-PHL-C2
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Active, not recruiting
- Enrollment
- 2,200
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •* Histologically confirmed primary diagnosis of classical Hodgkin’s lymphoma
- •* Patients under 18 years of age on the date of written informed consent. In specialised Teenage and Young Adult (TYA) units in France, Italy and UK patients under 25 years of age can also be enrolled. Lower age limits will be country specific according to national laws or formal insurance requirements that may preclude very young Patients.
- •* Written informed consent of the Patient and/or the Patient’s Parents or Guardian according to national laws
- •* Negative pregnancy test within 2 weeks prior to starting treatment for female Patients with childbearing potential
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 0
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range 0
Exclusion Criteria
- •Patients with one or more of the following criterion are excluded:
- •* Prior chemotherapy or radiotherapy for other malignancies
- •* Pre-treatment of Hodgkin’s lymphoma (except for 7-10 days steroid pre-phase of a large mediastinal tumour)
- •* Diagnosis of lymphocyte-predominant Hodgkin’s lymphoma
- •* Other (simultaneous) malignancies
- •* Contraindication or known hypersensitivity to study drugs
- •* Severe concomitant diseases (e.g. immune deficiency syndrome)
- •* Known HIV-positivity
- •* Residence outside the participating countries where long term follow-up cannot be guaranteed
- •* Pregnancy and/or lactation
- •* Patients who are sexually active and are unwilling to use adequate contraception during therapy and for one year after last trial treatment
- •* Current or recent (within 30 days prior to date of written informed consent) treatment with another investigational drug or participation in another interventional clinical trial
Investigators
Similar Trials
Active, not recruiting
Not Applicable
Second International Study for Treatment of Classical Hodgkin?s Lymphoma in Children and AdolescentsHodgkin lymphoma in children and adolescentsEUCTR2012-004053-88-ESJustus Liebig University of Giessen2,200
Active, not recruiting
Phase 1
First International Inter-Group Study for Classical Hodgkin’s Lymphoma in Children and Adolescents - EuroNet-PHL-C1Classic Hodgkin’s lymphoma in childhood and adolescenceMedDRA version: 9.1 Level: HLGT Classification code 10025319 Term: Lymphomas Hodgkin's diseaseEUCTR2006-000995-33-IEOur Lady's Children's Hospital1,200
Active, not recruiting
Phase 1
First International Inter-Group Study for Classical Hodgkin’s Lymphoma in Children and AdolescentsClassic Hodgkin’s lymphoma in childhood and adolescenceMedDRA version: 13.1Level: HLGTClassification code 10025319Term: Lymphomas Hodgkin's diseaseSystem Organ Class: 10005329 - Blood and lymphatic system disordersEUCTR2006-000995-33-GBMartin Luther University of Hallle/Wittenburg1,200
Active, not recruiting
Phase 1
First International Inter-Group Study for classical Hodgkin´s Lymfoma in Children and Adolescents - EuroNet-PHL-C1classic Hodgkin´s lymphomaEUCTR2006-000995-33-CZMartin Luther University of Halle/Wittenberg, Medizinische Fakultät, Prodekanat Forschung1,200
Completed
Phase 3
First international Inter-Group Study for classical Hodgkin's Lymphoma in Children and Adolescentsclassical Hodgkin's Lymphoma10025319NL-OMON41689Stichting Kinderoncologie Nederland34